Safety and early treatment effects of the CXCR2 antagonist SB-656933 in patients with cystic fibrosis.
暂无分享,去创建一个
R. Tal-Singer | E. Kerem | J. Pilewski | M. Konstan | R. Moss | A. Lazaar | Sunil J Mistry
暂无分享,去创建一个
R. Tal-Singer | E. Kerem | J. Pilewski | M. Konstan | R. Moss | A. Lazaar | Sunil J Mistry